Acquisitions drive expansion Myant has actively expanded through multiple acquisitions (Figur8, Bitnobi, mmHg, Nanoleq, Osmotex) to broaden its Internet of Humans platform, musculoskeletal intelligence, remote monitoring, and materials capabilities, signaling opportunities for cross-sell to adjacent health tech segments and integration projects.

Healthcare platform focus With a dedicated MyantHealth connected care platform for cardiovascular health and a mission to make healthcare equitable and efficient, there are clear sales avenues for hospitals and clinicians seeking continuous patient monitoring, early intervention, and family–care team connectivity.

AI driven care Recent launches and demonstrations (Care360, AI-driven solutions) position Myant as a partner for precision medicine, remote monitoring, and proactive care management, appealing to health systems and payer programs aiming to reduce risk and improve outcomes.

Strategic partnerships The company emphasizes textiles with sensing capabilities and a broad tech stack, suggesting readiness for collaboration with manufacturers, device integrators, and health IT vendors to embed textile sensors into consumer and patient garments, enabling scalable deployments.

Financially growing Current revenue range and modest funding indicate a growth phase with headroom for pilot programs and multi-site deployments; target opportunities include pilot collaborations, regional expansion, and joint ventures to accelerate go-to-market with healthcare networks.